Brookmont Capital Management grew its holdings in shares of DuPont de Nemours, Inc. (NYSE:DD - Free Report) by 146.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 39,645 shares of the basic materials company's stock after purchasing an additional 23,581 shares during the period. DuPont de Nemours makes up about 2.9% of Brookmont Capital Management's portfolio, making the stock its 5th biggest holding. Brookmont Capital Management's holdings in DuPont de Nemours were worth $5,149,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. State Street Corp boosted its holdings in DuPont de Nemours by 140.3% in the second quarter. State Street Corp now owns 44,941,824 shares of the basic materials company's stock worth $6,095,909,000 after acquiring an additional 26,238,300 shares in the last quarter. Bank of America Corp DE boosted its stake in DuPont de Nemours by 22.0% in the 1st quarter. Bank of America Corp DE now owns 4,629,671 shares of the basic materials company's stock worth $212,039,000 after purchasing an additional 835,572 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in DuPont de Nemours by 10.0% in the 1st quarter. Bank of New York Mellon Corp now owns 3,706,596 shares of the basic materials company's stock worth $169,762,000 after purchasing an additional 336,780 shares in the last quarter. Dimensional Fund Advisors LP grew its position in DuPont de Nemours by 4.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,509,831 shares of the basic materials company's stock worth $160,688,000 after purchasing an additional 163,210 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. grew its position in DuPont de Nemours by 16.4% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 971,901 shares of the basic materials company's stock worth $124,360,000 after purchasing an additional 137,070 shares during the last quarter. Institutional investors and hedge funds own 73.96% of the company's stock.
DuPont de Nemours Trading Up 1.0%
DuPont de Nemours stock opened at $136.47 on Friday. The stock has a 50-day moving average price of $132.24 and a 200 day moving average price of $138.11. The company has a market capitalization of $18.43 billion, a price-to-earnings ratio of 303.34, a price-to-earnings-growth ratio of 1.26 and a beta of 1.05. DuPont de Nemours, Inc. has a 52 week low of $100.00 and a 52 week high of $157.98. The company has a quick ratio of 1.82, a current ratio of 2.43 and a debt-to-equity ratio of 0.23.
DuPont de Nemours (NYSE:DD - Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.76 by $0.12. DuPont de Nemours had a net margin of 0.67% and a return on equity of 6.92%. The company had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same period last year, the firm posted $1.12 EPS. DuPont de Nemours's revenue for the quarter was up 4.0% compared to the same quarter last year. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. Sell-side analysts anticipate that DuPont de Nemours, Inc. will post 7.25 EPS for the current year.
DuPont de Nemours Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, November 30th will be given a dividend of $0.60 per share. The ex-dividend date is Monday, November 30th. This represents a $2.40 dividend on an annualized basis and a yield of 1.8%. DuPont de Nemours's payout ratio is currently 533.33%.
Analysts Set New Price Targets
A number of brokerages have issued reports on DD. UBS Group cut their price target on shares of DuPont de Nemours from $178.00 to $172.00 and set a "buy" rating on the stock in a research note on Monday, October 5th. Zacks Research downgraded shares of DuPont de Nemours from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 17th. Royal Bank Of Canada lowered their price objective on shares of DuPont de Nemours from $176.00 to $160.00 and set an "outperform" rating for the company in a research note on Thursday, October 15th. The Goldman Sachs Group dropped their price objective on shares of DuPont de Nemours from $159.00 to $153.00 and set a "neutral" rating on the stock in a report on Wednesday, September 30th. Finally, Barclays initiated coverage on DuPont de Nemours in a research report on Tuesday, October 13th. They issued an "overweight" rating and a $156.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $162.00.
View Our Latest Report on DD
DuPont de Nemours Company Profile
(
Free Report)
DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.
The company's product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.
See Also
Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DuPont de Nemours, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.
While DuPont de Nemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.